A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis — Stella
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(72 sites)
United States
Leo Pharma Investigational site, Birmingham, Alabama
Leo Pharma Investigational site, North Little Rock, Arkansas
Leo Pharma Investigational site, Palo Alto, California
Leo Pharma Investigational site, Sacramento, California
Leo Pharma Investigational site, San Diego, California
Leo Pharma Investigational site, San Diego, California
Leo Pharma Investigational site, Jacksonville, Florida
Leo Pharma Investigational site, Miami, Florida
Leo Pharma Investigational site, Tampa, Florida
Leo Pharma Investigational site, Macon, Georgia
Leo Pharma Investigational site, Waterford, Michigan
Leo Pharma Investigational site, Tulsa, Oklahoma
Leo Pharma Investigational site, Portland, Oregon
Leo Pharma Investigational site, Charleston, South Carolina
Leo Pharma Investigational site, Norfolk, Virginia
Belgium
Leo Pharma Investigational site, Brussels
Leo Pharma Investigational site, Ghent
Leo Pharma Investigational site, Leuven
Leo Pharma Investigational site, Liège
Canada
Leo Pharma Investigational site, Burlington
Leo Pharma Investigational site, Calgary
Leo Pharma Investigational site, Calgary
Leo Pharma Investigational site, Edmonton
Leo Pharma Investigational site, Edmonton
Leo Pharma Investigational site, Hamilton
Leo Pharma Investigational site, Niagara Falls
Leo Pharma Investigational site, Saskatoon
Leo Pharma Investigational site, Windsor
Leo Pharma Investigational site, Winnipeg
Croatia
Leo Pharma Investigational site, Rijeka
Leo Pharma Investigational site, Zagreb
Leo Pharma Investigational site, Zagreb
Germany
Leo Pharma Investigational site, Buxtehude
Leo Pharma Investigational site, Dresden
Leo Pharma Investigational site, Mainz
Leo Pharma Investigational site, Osnabrück
Leo Pharma Investigational site, Tübingen
Leo Pharma Investigational site, Wuppertal
Ireland
Leo Pharma Investigational site, Cork
Leo Pharma Investigational site, Crumlin
Italy
Leo Pharma Investigational site, Ancona
Leo Pharma Investigational site, Brescia
Leo Pharma Investigational site, Padova
Leo Pharma Investigational site, Roma
Leo Pharma Investigational site, Rome
Netherlands
Leo Pharma Investigational site, Utrecht
Poland
Leo Pharma Investigational site, Gdansk
Leo Pharma Investigational site, Krakow
Leo Pharma Investigational site, Lodz
Leo Pharma Investigational site, Ostrowiec Świętokrzyski